Table 4. Effect of the case-control status on the Acetylation ratios (log AFMU/1X) in subjects with different NAT2 genotypes.
Genotype | Status | Mean Log ratio (SD) | 95% CI min | 95% CI max | Inter-group comparison |
NAT2*4/*4 | Case (n = 7) | 0.273 (0.181) | 0.105 | 0.441 | |
Control (n = 29) | 0.341 (0.167) | 0.277 | 0.404 | p = 0.373 | |
NAT2*4/*5 | Case (n = 20) | 0.157 (0.197) | 0.065 | 0.249 | |
Control (n = 75) | 0.181 (0.117) | 0.154 | 0.209 | p = 0.605 | |
NAT2*4/*6 | Case (n = 8) | 0.166 (0.116) | 0.077 | 0.254 | |
Control (n = 58) | 0.197 (0.140) | 0.159 | 0.235 | p = 0.474 | |
NAT2*5/*5 | Case (n = 11) | −0.496 (0.134) | −0.405 | −0.586 | |
Control (n = 80) | −0.479 (0.141) | −0.447 | −0.510 | p = 0.705 | |
NAT2*5/*6 | Case (n = 20) | −0.595 (0.122) | −0.536 | −0.653 | |
Control (n = 95) | −0.543 (0.132) | −0.516 | −0.569 | p = 0.103 | |
NAT2*6/*6 | Case (n = 7) | −0.714 (0.087) | −0.633 | −0.795 | |
Control (n = 25) | −0.627 (0.158) | −0.563 | −0.691 | p = 0.173 |